Madrigal Pharmaceuticals, Inc. - Common Stock — 四半期財務統計 (NASDAQ:MDGL) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

営業活動によるキャッシュフロー -104.49 M-88.89 M-47.05 M79.85 M-133.46 M-167.44 M -268.1 M 投資活動によるキャッシュフロー -47.95 M163.88 M47.86 M-207 M27.58 M192.19 M 60.63 M 財務活動によるキャッシュフロー 19.77 M8.64 M1.74 M236.65 M8.96 M2.33 M 249.67 M フリーキャッシュフロー -104.49 M-88.89 M-47.05 M75.99 M-133.07 M-171.28 M -275.41 M

ニュース

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

Madrigal (MDGL) Reports Q1 Loss, Beats Revenue Estimates

Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out for

Madrigal (MDGL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Altimmune Catalysts: 2026 Data Readouts and Financing Risks

ALT Stock: What Pemvidutide Means for MASH, AUD and ALD

Is Altimmune a Buy Before Phase III MASH Starts in 2026?

United Therapeutics (UTHR) Up 5.7% Since Last Earnings Report: Can It Continue?

Madrigal (MDGL) Surges 12.3%: Is This an Indication of Further Gains?

Why Is Corcept (CORT) Up 11.7% Since Last Earnings Report?

ALT Stock and the 2026 MASH Race: Dual Agonists vs. New Mechanisms

ALT Pemvidutide Explained: What Makes It Different in MASH